Strengthening of Pharmaceutical Industry (SPI) scheme

March 12, 2022

The guidelines for the scheme “Strengthening of Pharmaceutical Industry (SPI)” were published by the Department of Pharmaceuticals, Ministry of Chemicals, and Fertilizers.

Overview of the Scheme

The total financial outlay of the scheme is Rs.500 Cr for three years (FY 21-22 to FY 25-26). The scheme aims to support the Pharmaceutical clusters and Micro, Small, and Medium Enterprises (MSMEs) in improving their productivity, quality, and sustainability.

Three Sub-schemes

Assistance to Pharmaceutical Industry for Common Facilities (APICF):
- This scheme is to strengthen the capacity of existing pharma clusters’ and ensure their sustained growth. A financial outlay of 178 Cr is proposed to support the creation of common facilities like R&D Labs, Testing Labs, Effluent Treatment Plants, Logistic Centers, and Training Centers in this order of priority.
Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS):
- This scheme is to facilitate MSMEs to meet national and international regulatory standards (WHO-GMP or Schedule-M). With a financial outlay of 300 Cr, interest subvention on capital loans of up to a maximum of 5% per annum (6% in case of units owned by SC/STs) or Credit linked Capital subsidy of 10% is proposed.
Pharmaceutical & Medical Devices Promotion and Development Scheme (PMPDS):
- This is to facilitate the growth of Pharma and Medical Devices Sectors by promoting knowledge and awareness about the Pharma and MedTech Industry. 21.5 Cr has been earmarked for this component of the scheme.

The scheme helps in strengthening the infrastructure facilities and positioning India as a global leader in the Pharmaceutical Sector.

« Previous PostNext Post »